SG/CALL/ABBOTT LABORATORIES/120/0.1/20.09.24 Share Price

Warrant

DE000SQ3G812

Market Closed - Deutsche Boerse AG 20:40:48 14/06/2024 BST
0.08 EUR +5.26% Intraday chart for SG/CALL/ABBOTT LABORATORIES/120/0.1/20.09.24
Current month+33.33%
1 month-10.11%
Date Price Change
14/06/24 0.08 +5.26%
13/06/24 0.076 -13.64%
12/06/24 0.088 -20.00%
11/06/24 0.11 -21.43%
10/06/24 0.14 0.00%

Delayed Quote Deutsche Boerse AG

Last update June 14, 2024 at 08:40 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Société Générale Société Générale
WKN SQ3G81
ISINDE000SQ3G812
Date issued 27/10/2022
Strike 120 $
Maturity 20/09/2024 (96 Days)
Parity 10 : 1
Emission price 1.08
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.51
Lowest since issue 0.044
Spread 0.01
Spread %10.99%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
103.7 USD
Average target price
125.4 USD
Spread / Average Target
+20.92%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW